Adalimumab reduces spinal symptoms in active ankylosing spondylitis: clinical and magnetic resonance imaging results of a fifty-two-week openlabel trial

被引:123
作者
Haibel, H [1 ]
Rudwaleit, M
Brandt, HC
Grozdanovic, Z
Listing, J
Kupper, H
Braun, J
Sieper, J
机构
[1] Klinikum Benjamin Franklin, D-12200 Berlin, Germany
[2] German Rheumatism Res Ctr, Berlin, Germany
[3] Abbott GmbH & Co, Ludwigshafen, Germany
[4] Ctr Rheumatol Ruhrgebiet, Herne, Germany
来源
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 02期
关键词
D O I
10.1002/art.21563
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:678 / 681
页数:4
相关论文
共 19 条
[1]   Development and preselection of criteria for short term improvement after anti-TNFα treatment in ankylosing spondylitis [J].
Brandt, J ;
Listing, J ;
Sieper, J ;
Rudwaleit, M ;
van der Heijde, D ;
Braun, J .
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (11) :1438-1444
[2]   Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis [J].
Brandt, J ;
Listing, J ;
Haibel, H ;
Sörensen, H ;
Schwebig, A ;
Rudwaleit, M ;
Sieper, J ;
Braun, J .
RHEUMATOLOGY, 2005, 44 (03) :342-348
[3]   Treatment of active ankylosing spondylitis with infliximab:: a randomised controlled multicentre trial [J].
Braun, J ;
Brandt, J ;
Listing, J ;
Zink, A ;
Alten, R ;
Golder, W ;
Gromica-Ihle, E ;
Kellner, H ;
Krause, A ;
Schneider, M ;
Sörensen, H ;
Zeidler, H ;
Thriene, W ;
Sieper, J .
LANCET, 2002, 359 (9313) :1187-1193
[4]   Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab - Evaluation of a new scoring system [J].
Braun, J ;
Baraliakos, X ;
Golder, W ;
Brandt, J ;
Rudwaleit, M ;
Listing, J ;
Bolow, M ;
Sieper, J ;
van der Heijde, D .
ARTHRITIS AND RHEUMATISM, 2003, 48 (04) :1126-1136
[5]  
Braun J, 1998, ARTHRITIS RHEUM-US, V41, P58, DOI 10.1002/1529-0131(199801)41:1<58::AID-ART8>3.3.CO
[6]  
2-7
[7]  
BRAUN J, 2004, ARTHRITIS RHEUM, V50, P4104
[8]  
CALIN A, 1994, J RHEUMATOL, V21, P2281
[9]   Recombinant human tumor necrosis factor receptor, (etanercept) for treating ankylosing spondylitis - A randomized, controlled trial [J].
Davis, JC ;
van der Heijde, D ;
Braun, J ;
Dougados, M ;
Cush, J ;
Clegg, DO ;
Kivitz, A ;
Fleischmann, R ;
Inman, R ;
Tsuji, W .
ARTHRITIS AND RHEUMATISM, 2003, 48 (11) :3230-3236
[10]  
GARRETT S, 1994, J RHEUMATOL, V21, P2286